Related Experiment Video

Updated: Jun 17, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells

Kathryn E Reinicke1, Mary J Kuffel, Matthew P Goetz

  • 1Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.

Cancer Chemotherapy and Pharmacology
|December 17, 2009
PubMed
Abstract

Insights

Aminoflavone enhances cancer cell killing when combined with paclitaxel or camptothecin. This DNA damaging agent shows synergistic effects in breast cancer cells, suggesting improved therapeutic potential in combination regimens.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Aminoflavone is a novel DNA damaging agent evaluated as a prodrug (AFP464).
  • Investigating drug interactions is crucial for optimizing combination cancer therapies.
  • MCF-7 breast cancer cells provide a relevant model for evaluating cytotoxic effects.

Purpose of the Study:

  • To assess synergistic interactions between aminoflavone and other anticancer drugs.
  • To determine the impact of combinations on cancer cell killing in MCF-7 cells.
  • To explore mechanisms underlying aminoflavone activity in combination therapy.

Main Methods:

  • Colony formation assays were used to evaluate cell survival after drug exposure.
  • Drug uptake, retention, and efflux were compared between single and combination treatments.
  • CYP1A1/1A2 induction and metabolite binding to macromolecules were investigated.

Main Results:

  • Aminoflavone demonstrated synergistic cytotoxicity with paclitaxel, camptothecin, and SN38.
  • Drug uptake and efflux were not significantly altered by combination treatments.
  • Paclitaxel did not inhibit aminoflavone metabolite DNA binding, whereas camptothecin did.

Conclusions:

  • Aminoflavone exhibits a unique mechanism of action, positioning it as a promising breast cancer therapeutic.
  • Combination therapy with aminoflavone and paclitaxel or camptothecin may enhance cytotoxic outcomes.
  • Further clinical evaluation of aminoflavone in combination regimens is warranted.

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...